Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2015) |  Total Docs. (3years) |
Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Drug Design, Development and Therapy | journal | 0.982 Q2 | 94 | 527 | 424 | 23818 | 1498 | 422 | 3.44 | 45.20 |  |
| 2 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.463 Q1 | 64 | 57 | 153 | 2744 | 697 | 149 | 4.77 | 48.14 | |
| 3 | Infection and Drug Resistance | journal | 1.263 Q1 | 65 | 39 | 82 | 2276 | 321 | 82 | 4.32 | 58.36 | |
| 4 | Drug, Healthcare and Patient Safety | journal | 0.531 Q3 | 30 | 17 | 66 | 635 | 123 | 60 | 1.76 | 37.35 | |
| 5 | Pharmacogenomics and Personalized Medicine | journal | 1.195 Q1 | 37 | 15 | 63 | 858 | 275 | 63 | 4.46 | 57.20 | |
| 6 | Biomarker Insights | journal | 0.800 Q2 | 40 | 68 | 45 | 5487 | 111 | 44 | 1.83 | 80.69 | |
| 7 | Clinical Medicine Insights: Therapeutics | journal | 0.186 Q4 | 11 | 8 | 39 | 684 | 19 | 39 | 0.76 | 85.50 | |
| 8 | Core Evidence (discontinued) | journal | 1.051 Q2 | 29 | 8 | 32 | 471 | 130 | 31 | 4.30 | 58.88 | |
| 9 | Journal of Receptor, Ligand and Channel Research | journal | 0.223 Q3 | 13 | 5 | 13 | 470 | 11 | 13 | 0.64 | 94.00 | |
| 10 | Perspectives in Medicinal Chemistry | journal | 1.285 Q1 | 17 | 3 | 5 | 193 | 29 | 5 | 5.80 | 64.33 | |
| 11 | Journal of Experimental Pharmacology | journal | 0.323 Q3 | 23 | 4 | 4 | 322 | 9 | 4 | 3.00 | 80.50 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data